Microvascular obstruction after primary percutaneous coronary intervention: pathogenesis, diagnosis and prognostic

Giampaolo Niccoli1, Nicola Cosentino, Silvia Minelli

  • 1Institute of Cardiology, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, Rome, Italy. gniccoli73@hotmail.it

Insights

Microvascular obstruction (MVO) can occur after opening blocked arteries in ST-elevation myocardial infarction. Early detection and prevention of MVO are crucial for improving patient prognosis and outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Research

Background:

  • Restoring blood flow to the heart muscle is key after ST-elevation myocardial infarction (STEMI).
  • Microvascular obstruction (MVO) can persist despite successful artery opening, impacting patient outcomes.
  • MVO pathogenesis involves ischemia, reperfusion injury, and embolization.

Purpose of the Study:

  • To review the pathogenesis, diagnosis, and prognostic significance of MVO in STEMI patients.
  • To highlight the importance of MVO prevention and early detection.
  • To discuss current diagnostic methods for MVO.

Main Methods:

  • Review of existing literature on microvascular obstruction in STEMI.
  • Analysis of diagnostic tools including angiography (TIMI, MBG), coronary flow, and imaging (MCE, CMR).
  • Evaluation of prognostic implications of MVO.

Main Results:

  • MVO is a significant complication associated with worse short- and long-term prognosis after primary PCI.
  • Various methods exist for MVO assessment, from immediate angiographic indexes to later imaging techniques.
  • Understanding MVO pathogenesis is key to developing preventative strategies.

Conclusions:

  • Microvascular obstruction is a critical factor influencing outcomes in STEMI patients post-reperfusion.
  • Early identification and management of MVO are essential for improving patient prognosis.
  • Further research into MVO prevention and treatment is warranted.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...